The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Bobby Thomas and M. Flint Beal | Feb 1, 2011 | 10 min read
The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure.
Crowdsourcing biomedical research; bird flu contagion?; zebrafish shed light on inherited muscle disorder; the economics of the Human Genome Project; the epigenetics of pair bonding
From determining structures to figuring out functions, brain-mapping scientists are applying new technologies to understand the hub of the central nervous system.
Glial cells were once considered neurons’ supporting actors, but new methods and model organisms are revealing their true importance in brain function.
Neuroscientists are automating neural imaging and recording, allowing them to monitor increasingly large swaths of the brain in living, behaving animals.